Business - Additional Information (Details) $ / shares in Units, $ in Thousands					1 Months Ended	12 Months Ended
	Apr. 19, 2021 USD ($) $ / shares shares	Apr. 15, 2021 shares	Apr. 14, 2021 shares	Apr. 01, 2021 Physician Dce	Apr. 30, 2021 USD ($) shares	Dec. 31, 2022 USD ($) Segment Medicare shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares
Subsidiary Sale Of Stock [Line Items]
Number Of Medicare Advantage Members Enrolled With Private Health Plans | Medicare						269,500
Number of Operational in States | Segment						1
Number of operations in States | Segment						8
Number of Direct Contracting Entities | Dce				5
Number of physician group partners | Physician				7
Number of shares issued and sold | shares					11,700,000			1,200,000
Shares sold, price per share | $ / shares	$ 23.00
Proceeds from initial public offering						$ 0	$ 1,170,942	$ 0
Number of shares issued under share-based awards | shares	11,700,000					12,300,000	9,300,000	2,300,000
Stock-based compensation expense					$ 2,600	$ 28,381	$ 292,394	$ 6,472
Former Chief Executive Officer | Employee Severance
Subsidiary Sale Of Stock [Line Items]
Severance Costs					3,700
Options Vesting
Subsidiary Sale Of Stock [Line Items]
Stock-based compensation expense					$ 268,500
loan to partner for taxes payable on share distribution							$ 76,800
Common Stock
Subsidiary Sale Of Stock [Line Items]
Number of shares issued and sold | shares							53,590,000	1,235,000
Common Stock | Two Thousand And Twenty One Omnibus Equity Incentive Plan
Subsidiary Sale Of Stock [Line Items]
Number of shares issued under share-based awards | shares					1,900,000
IPO
Subsidiary Sale Of Stock [Line Items]
Number of shares issued and sold | shares	53,600,000
Estimated offering costs	$ 7,800
Stock-based compensation expense					$ 268,500	$ 2,600
IPO | Common Stock
Subsidiary Sale Of Stock [Line Items]
Proceeds from initial public offering	$ 1,200,000
Number of shares issued under share-based awards | shares	53,600,000	7,000,000.0	46,600,000